MedMesh.i
Corpus
PubMed
Racine
Corpus
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Norepinephrine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nonlinear Dynamics < Norepinephrine < Norepinephrine Plasma Membrane Transport Proteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000547 (2014) Safa Bouabid ; Claire Delaville ; Philippe De Deurwaerdère ; Nouria Lakhdar-Ghazal ; Abdelhamid BenazzouzManganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat.
000869 (2012) M. Sabbar ; C. Delaville ; P. De Deurwaerdère ; A. Benazzouz ; N. Lakhdar-GhazalLead intoxication induces noradrenaline depletion, motor nonmotor disabilities, and changes in the firing pattern of subthalamic nucleus neurons.
000895 (2012) C. Delaville ; S. Navailles ; A. BenazzouzEffects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
000A69 (2010) David Devos ; L. Defebvre ; R. BordetDopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
000E83 (2006) Jean-Pierre Wolf ; Malika Bouhaddi ; Francis Louisy ; Andrei Mikehiev ; Laurent Mourot ; Sylvie Cappelle ; Fabrice Vuillier ; Pierre Andre ; Lucien Rumbach ; Jacques RegnardSide-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment.
000F42 (2005) Philippe Remy ; Miroslava Doder ; Andrew Lees ; Nora Turjanski ; David BrooksDepression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.
001173 (2002) Christine Brefel-Courbon[Parkinson disease and the noradrenaline system].
001176 (2002) Anne-Marie Bonnet[Alpha-2 adrenergic receptors and Parkinson's disease].
001220 (2002) L. Cathala ; A. Guyon ; D. Eugene ; D. Paupardin-TritschAlpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra.
001438 (1999) O. RascolL-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
001562 (1996) M E Llau ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L MontastrucA study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
001647 (1995) H. Lefebvre ; C. Noblet ; N. Moore ; L M WolfPseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
001648 (1995) R M Marié ; L. Barré ; P. Rioux ; P. Allain ; B. Lechevalier ; J C BaronPET imaging of neocortical monoaminergic terminals in Parkinson's disease.
001679 (1994) M. Galinier ; J M Senard ; P. Valet ; J P Doazan ; G. Durrieu ; M A Tran ; J L Monstastruc ; J P BounhoureRelationship between arterial blood pressure disturbances and alpha adrenoceptor density.
001727 (1993) M. BrileyNoradrenergic mechanisms in Parkinson's disease.
001783 (1991) P. Gaspar ; C. Duyckaerts ; C. Alvarez ; F. Javoy-Agid ; B. BergerAlterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease.
001797 (1991) G. Durrieu ; J M Senard ; M A Tran ; A. Rascol ; J L MontastrucEffects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
001811 (1990) G. Durrieu ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. MontastrucBeta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
001812 (1990) J M Senard ; P. Valet ; G. Durrieu ; M. Berlan ; M A Tran ; J L Montastruc ; A. Rascol ; P. MontastrucAdrenergic supersensitivity in parkinsonians with orthostatic hypotension.
001823 (1990) G. Durrieu ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L MontastrucBlood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Norepinephrine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Norepinephrine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Norepinephrine
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024